IMDX

Insight Molecular Diagnostics Inc. Common Stock
IMDX

Overview Fund Activity

26 hedge funds and large institutions have $11.4M invested in Insight Molecular Diagnostics Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.

Holders
26
Holders Change
-4
Holders Change %
-13.33%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
8
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$615K
2
AIC
2
AWM Investment Company
New York
$1.87M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$620K
4
TRCT
4
Tower Research Capital (TRC)
New York
$8.32K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$32K

Top Sellers

1
PVI
1
Pura Vida Investments
New York
$1.47M
2
DC
2
Defender Capital
North Carolina
$179K
3
Millennium Management
3
Millennium Management
New York
$0
4
Osaic Holdings
4
Osaic Holdings
Arizona
$242
5
BlackRock
5
BlackRock
New York
$150K
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
$2 – – –
Millennium Management
27
Millennium Management
New York
– -$48.4K -14,754 Closed
US Bancorp
28
US Bancorp
Minnesota
– -$78 -25 Closed
MAM
29
Meeder Asset Management
Ohio
– -$28 -9 Closed
1
2